AzTrials
AzTrials

Psychotic DisordersCTI-PSNCT05945277

Critical Time Intervention-Peer Support

A study testing Critical Time Intervention - Peer Support in people with Psychotic Disorders and Schizophrenia, run by Lisbon Institute of Global Mental Health - LIGMH at 3 sites in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

There is increasing awareness of the importance of providing mental health services and support that promote a recovery-oriented and human rights-based approach. A mental health service system that is guided by a rehabilitation and recovery perspective places emphasis on treating the consequences of the illness rather… Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Critical Time Intervention - Peer Support
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
3 sitesPortugal
Study dates
1 Jul 2023to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18-65 years of age.
  • Any psychotic disorder diagnosis based on the International Classification of Diseases - 10th revision (ICD-10) criteria, including both non-affective (e.g., schizophrenia) and affective psychosis (e.g., bipolar disorder)
  • Having been discharged from inpatient psychiatric treatment facilities in the month prior to recruitment

Who cannot join

  • Active suicidal ideation.
  • Cognitive, neurological, or other sensorial conditions likely to preclude or affect an objective assessment via interview procedures

Trial locations and contacts

3 sites in 1 country.

Manuela Silva, M.D., PhD contact

+351938711317

manuela.silva@gmail.com

Portugal3 sites, 3 recruiting
  • Centro Hospitalar Lisboa Ocidental

    Lisbon

    Joaquim Gago, joaquimgago@me.com

    Recruiting
  • Centro Hospitalar Universitário Lisboa Norte

    Lisbon

    Manuela Silva, M.D., PhD, +351938711317, manuela.silva@gmail.com

    Recruiting
  • Hospital Beatriz Ângelo

    Loures

    Maria João Heitor, M.D., PhD, maria.heitor@hbeatrizangelo.pt

    Recruiting

Other trials in Portugal

About this study

Official title: Effectiveness of the Critical Time Intervention-Peer Support (CTI-PS) Model for Persons With Serious Mental Illness Discharged From Inpatient Psychiatric Treatment Facilities in Portugal

There is increasing awareness of the importance of providing mental health services and support that promote a recovery-oriented and human rights-based approach. A mental health service system that is guided by a rehabilitation and recovery perspective places emphasis on treating the consequences of the illness rather than just the illness "per se", and on empowering people to regain control of their identity and life, and to have hope for the future. Within this philosophy, mental health policies in several countries advocate for the introduction of peer workers in mental health services, people with lived experience of mental health issues and recovery, who are employed to use their lived experience to support those who access mental health services. However, more effectiveness and implementation research is needed. Evidence also suggests that the period following hospital discharge is of high risk of treatment dropout for people with serious mental illness, thus interrupting their recovery process. Therefore, this vulnerable population may particularly benefit from more targeted interventions during this transitional period.

The research project will conduct a pilot randomized controlled trial to evaluate the feasibility, implementation and potential effectiveness of the Critical Time Intervention-Peer Support model, a recovery-oriented based model for people with serious mental illness discharged from inpatient psychiatric treatment facilities in Portugal. The randomized controlled trial (RCT) will be conducted in three psychiatric services in the Lisbon Metropolitan Area and their catchment areas. People with diagnoses of psychotic disorders discharged from inpatient psychiatric treatment facilities will be recruited and randomly divided into CTI-PS intervention or usual care. Those allocated to the intervention group will additionally receive CTI-PS rather than usual care alone over a 9-month period. Outcomes at baseline, 9- and 18-months will be analyzed by multilevel models, considering the observations clustered within sites. Longitudinal analyses will be used to examine trends over time of the outcomes of interest.

The implementation of the CTI-PS model will introduce a novel approach to community mental health care that has not yet been tried in Portugal. This study aims to explore to what extent this intervention can be effectively implemented in countries with the characteristics of Portugal. Additionally, the proposed research aims to contribute to the global knowledge about peer interventions by exploring whether the CTI model can maintain its effectiveness using peers.

Read the detailed description

Critical Time Intervention-Peer Support is delivered by Community Mental Health Workers (CMHWs) and Peer Support Workers (PSWs). They will be selected, recruited, and trained by members of the research team to deliver mental health care according to the manualized recovery-oriented program. Ongoing regular supervision of PSWs and CMHWs, in weekly meetings, will be conducted throughout the study by members of the research team trained in CTI-PS by those who originally developed it at the Columbia University.

Those allocated to the intervention group will receive usual care and, in addition, CTI-PS services over a 9-month period.

The intervention has two broad objectives: 1) to collaborate with participants to develop durable connections to support systems, including both formal and informal supports (e.g., mental health services, primary care clinics, family, and friends); and 2) to provide practical and emotional support, helping the individual to overcome a critical period of transition during which they can feel especially vulnerable.

The work of CTI-PS will focus on areas identified as crucial for strengthening the individual's continuum of services and forming enduring links with their community supports. The phases of CTI are Initiation, Try-Out, and Transfer of Care. The PSW-CMHW will collaborate with the participants to identify barriers to their recovery and develop a sustainable plan to engage in and use community supports and resources during and after CTI. They will also use their knowledge to increase participants' autonomy, strengthen their connection to health services, and expand their support networks. The role of CTI workers is specifically designed to avoid becoming the primary source of care for the individual.

Being tested
Critical Time Intervention - Peer Support
Keywords
Recovery, Peer support, Severe mental illness
Medical subject headings
Psychotic Disorders, Schizophrenia, Bipolar Disorder, Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Critical Time Intervention - Peer SupportBehavioural

    CTI-PS is a time-limited, 9-month long intervention, provided at the critical time when a person is discharged from an inpatient psychiatric treatment facility.

Study groups in NCT05945277
Study groupRoleWhat they receive
ControlNo interventionNot described
InterventionExperimentalNot described
Receives: Behavioral: Critical Time Intervention - Peer Support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. WHOQOL-BREF

    Health-related quality of life, assessed by the WHO Quality of Life Scale - Brief Version (WHOQOL-BREF). This instrument has 26 items and measures the following domains: physical and psychological health, social relationships, and environment, with two additional general questions.

    Measured: 18 months

  2. Camberwell Assessment of Need (CAN)

    Unmet needs, assessed by the Camberwell Assessment of Need (CAN), which evaluates 22 areas of need such as accommodation, food, safety to self, among others.

    Measured: 18 months

Secondary outcomes (5)
  1. Psychopathology, assessed by the Brief Psychiatric Rating Scale (BPRS)

    Measured: 18 months

  2. Level of disability, assessed by the WHO Disability Assessment Schedule (WHODAS 2.0)

    Measured: 18 months

  3. Orientation toward recovery, assessed by the INSPIRE - Research Into Recovery

    Measured: 18 months

  4. Self-stigma, assessed by the Internalized Stigma of Mental Illness (ISMI)

    Measured: 18 months

  5. Substance use, assessed by the WHO Alcohol, Smoking and Substance Involvement Screening Test Schedule (WHO ASSIST)

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2023
  2. Study start1 Jul 2023
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05945277
Sponsor's protocol ID
CTI-PS
Acronym
CTI-PS
Status last verified
Jun 2024
First submitted
6 Jul 2023
Last updated
1 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Critical Time Intervention - Peer Support in people with Psychotic Disorders and Schizophrenia, run by Lisbon Institute of Global Mental Health - LIGMH at 3 sites in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Manuela Silva, M.D., PhD (+351938711317, manuela.silva@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

WHOQOL-BREF (time frame: 18 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in